Adjuvant testosterone therapy in chronic heart failure (ATTIC): a randomised open-label trial

Introduction Heart failure is a major contributor to morbidity and mortality in the geriatric population, with no promising therapy currently available with considerable benefit. Testosterone therapy is an emerging viable treatment option given its beneficial effects, including improving cardiac fun...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Manu Sharma, Sanjay Kalra, Minakshi Dhar, Kartik Mittal, Ashwin Parchani, Yogesh Bahurupi, Nowneet Kumar Bhat
التنسيق: مقال
اللغة:English
منشور في: BMJ Publishing Group 2022-05-01
سلاسل:BMJ Open
الوصول للمادة أونلاين:https://bmjopen.bmj.com/content/12/5/e056994.full